Expertise in
14
conditions

Reena Sharma

Stott Lane, 
Salford, ENG, GB 
Expertise in
14
conditions
Stott Lane, 
Salford, ENG, GB 

Overview

Reena Sharma practices practicing medicine in Salford, United Kingdom.

Ms. Sharma is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Cholesteryl Ester Storage Disease, Lysosomal Acid Lipase Deficiency, Wolman Disease, Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), and Gastrostomy.

She is actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 9 clinical trials.

Gender

Female

Locations

Stott Lane, Salford, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
PEACE (Pegzilarginase Effect on Arginase 1 Deficiency Clinical Endpoints): A Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Efficacy and Safety of Pegzilarginase in Children and Adults With Arginase 1 Deficiency
Enrollment Status: Completed
Publish Date: August 21, 2026
Intervention Type: Drug
Study Drug: PEG-Zilarginase
Study Phase: Phase 3
Effects of N-Acetyl-L-Leucine on GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study
Effects of N-Acetyl-L-Leucine on GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study
Enrollment Status: Completed
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drug: IB1001
Study Phase: Phase 2
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Drug
Effects of N-Acetyl-L-Leucine on Niemann Pick Type C Disease: A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study.
Effects of N-Acetyl-L-Leucine on Niemann Pick Type C Disease: A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study.
Enrollment Status: Completed
Publish Date: November 28, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1/2 Multiple Ascending-Dose Study in Subjects With Homocystinuria Due to Cystathionine β-Synthase (CBS) Deficiency to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of ACN00177
A Phase 1/2 Multiple Ascending-Dose Study in Subjects With Homocystinuria Due to Cystathionine β-Synthase (CBS) Deficiency to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of ACN00177
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of KB195 in Subjects With A Urea Cycle Disorder With Inadequate Control on Standard of Care
A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of KB195 in Subjects With A Urea Cycle Disorder With Inadequate Control on Standard of Care
Enrollment Status: Terminated
Publish Date: January 25, 2022
Intervention Type: Drug
Study Drug: KB195
Study Phase: Phase 2
A Multi-Center, Open-Label, Randomized Study Evaluating the Safety and Efficacy of Three Dosing Regimens of Replagal Enzyme Replacement Therapy in Adult Patients With Fabry Disease
A Multi-Center, Open-Label, Randomized Study Evaluating the Safety and Efficacy of Three Dosing Regimens of Replagal Enzyme Replacement Therapy in Adult Patients With Fabry Disease
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Biological
Study Phase: Phase 3
An Open-label Extension of Study TKT028 Evaluating Safety and Clinical Outcomes of Replagal® Enzyme Replacement Therapy Administered to Adult Patients With Fabry Disease
An Open-label Extension of Study TKT028 Evaluating Safety and Clinical Outcomes of Replagal® Enzyme Replacement Therapy Administered to Adult Patients With Fabry Disease
Enrollment Status: Completed
Publish Date: June 08, 2021
Intervention Type: Biological
Study Phase: Phase 3
MPS VI Clinical Surveillance Program (CSP)
MPS VI Clinical Surveillance Program (CSP)
Enrollment Status: Completed
Publish Date: April 05, 2021
View 8 Less Clinical Trials

48 Total Publications

Natural history of hearing loss in adults with mucopolysaccharidoses across phenotype and genotype.
Natural history of hearing loss in adults with mucopolysaccharidoses across phenotype and genotype.
Journal: Molecular genetics and metabolism
Published: February 21, 2026

Frequently Asked Questions about Reena Sharma

Is Reena Sharma a top-rated expert for Cholesteryl Ester Storage Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Reena Sharma is classified as an Distinguished expert for Cholesteryl Ester Storage Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Reena Sharma participate in research or clinical trials?

Yes. Reena Sharma has published 48 articles and abstracts on conditions like Cholesteryl Ester Storage Disease. You can view a list of Reena Sharma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Sharma's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile